Tobacco Cessation Texting Intervention for People Living With HIV Who Smoke in Vietnam
Launched by UNIVERSITY OF MASSACHUSETTS, WORCESTER · May 8, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
M2Q2-HIV \[mHealth Messaging to Motivate Quitline Use and Quitting among Persons Living with HIV (PLWH) in Vietnam (M2Q2-HIV)\] is an adaptation of a current computer-tailored smoking cessation intervention in Vietnam. Study investigators seek to promote underused government resources for public health (the Quitline) and Nicotine Replacement Therapy (NRT) among PLWH in a sustainable manner.
Investigators will test M2Q2-HIV by conducting a randomized control trial with 600 PLWH smokers in two provinces in Northern Vietnam (26 clinics; 9,877 HIV patients).
In Aim 1, study investigators will...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Diagnosed HIV infection (prevalent and incident HIV).
- • 2. At least 18 years old.
- • 3. Current smoker.
- • 4. Be able to receive texts and read text (literate).
- Exclusion Criteria:
- • 1. Pregnant or planning to become pregnant during the next six months.
- • 2. Unable or unwilling to provide informed consent.
- • 3. Prior diagnosis of serious mental health illness.
- • 4. Smoker who helped develop the motivational texts used in the intervention (participated in Aim 1).
- • 5. Family member of another participant in the study.
About University Of Massachusetts, Worcester
The University of Massachusetts Worcester is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the university integrates cutting-edge scientific inquiry with a commitment to improving patient outcomes. Its collaborative approach engages a diverse range of experts, fostering interdisciplinary research that addresses pressing health challenges. With a focus on ethical standards and regulatory compliance, the University of Massachusetts Worcester plays a pivotal role in translating scientific discoveries into practical applications that enhance medical practice and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hanoi, , Vietnam
Worcester, Massachusetts, United States
Patients applied
Trial Officials
Rajani S Sadasivam, PhD
Principal Investigator
University of Massachusetts Chan Medical School
Hoa T Nguyen, MD, MS, PhD
Principal Investigator
University of Massachusetts Chan Medical School
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported